8202 Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices 

Dated: February 1, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–02358 Filed 2–3–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10292] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by March 8, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

2. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: State Medicaid 

HIT Plan, Planning Advance Planning 

Document, and Implementation 

Advance Planning Document for 

Section 4201 of the Recovery Act; Use: 

To assess the appropriateness of state 

requests for the administrative Federal 

financial participation for expenditures 

under their Medicaid Electronic Health 

Record Incentive Program related to 

health information exchange, our staff 

will review the submitted information 

and documentation to make an approval 

determination of the state advance 

planning document. Form Number: 

CMS–10292 (OMB control number: 

0938–1088); Frequency: Once and 

occasionally; Affected Public: State, 

Local, and Tribal Governments; Number 

of Respondents: 56; Total Annual 

Responses: 56; Total Annual Hours: 

896. (For policy questions regarding this 

collection contact Edward Dolly at 410– 

786–8554.) 

Dated: February 1, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–02319 Filed 2–3–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct; 

Correction 

AGENCY: Office of the Secretary, HHS. 

ACTION: Correction of notice. 

SUMMARY: This document corrects errors 

that appeared in the notice published in 

the November 7, 2019, Federal Register 

entitled ‘‘Findings of Research 

Misconduct.’’ 

DATES: 

Effective Date: February 4, 2021. 

Applicability Date: The correction 

notice is applicable for the Findings of 

Research Misconduct notice published 

on November 7, 2019. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Karen Gorirossi or Dr. Alexander Runko 

at 240–453–8800. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In FR Doc. 2019–24291 of November 

7, 2019 (84 FR 60097–60098), there 

were errors involving incorrect citations 

for published papers affecting six 

paragraphs on page 60098. The errors 

are identified and corrected in the 

Correction of Errors section below. 

II. Correction of Errors 

In FR Doc. 2019–24291 of November 

7, 2019 (84 FR 60097–60098), make the 

following corrections: 

1. On page 60098, first column, in FR 

Doc. 2019–24291, fifth paragraph, lines 

1–2, change ‘‘Am. J. Physiol. Lung Cell. 

Mol. Biol.’’ to ‘‘Am. J. Resp. Cell. Mol. 

Biol.’’ and in lines 3–5, remove 

‘‘(hereafter referred to as ‘‘Am. J. 

Physiol. Lung Cell. Mol. Biol. 2011b 

paper).’’ 

2. On page 60098, first column, in FR 

Doc. 2019–24291, twelfth paragraph, 

lines 1–2, change ‘‘Am. J. Physiol. Lung 

Cell. Mol. Biol.’’ to ‘‘Am. J. Resp. Cell. 

Mol. Biol.’’ 

3. On page 60098, first column, in FR 

Doc. 2019–24291, sixteenth paragraph, 

lines 1–2, change ‘‘J. Immunol. 

2007;2179:4367–75’’ to ‘‘J. Immunol. 

2007;179:4367–75.’’ 

4. On page 60098, second column, in 

FR Doc. 2019–24291, second paragraph, 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 22 / Thursday, February 4, 2021 / Notices 8203 

lines 2–3, change ‘‘Am. J. Physiol. Lung 

Cell. Mol. Biol.’’ to ‘‘Am. J. Resp. Cell. 

Mol. Biol.’’ 

5. On page 60098, second column, in 

FR Doc. 2019–24291, sixth paragraph, 

lines 1 and 3, change ‘‘J. App. Physiol.’’ 

to ‘‘J. Appl. Physiol.’’ 

6. On page 60098, second column, in 

FR Doc. 2019–24291, twenty-third 

paragraph, lines 1–2, change ‘‘Am. J. 

Physiol. Lung Cell. Mol. Biol. 2011b 

paper’’ to ‘‘Am. J. Physiol. Lung Cell. 

Mol. Physiol. 2011;301(3):L327–L333.’’ 

Dated: January 29, 2021. 

Wanda K. Jones, 

Acting Director, Office of Research Integrity. 

[FR Doc. 2021–02272 Filed 2–3–21; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Research Misconduct 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Findings of research 

misconduct have been made against 

Yibin Lin, Ph.D. (Respondent), former 

postdoctoral fellow, McGovern Medical 

School, University of Texas Health 

Science Center (UTHealth). Respondent 

engaged in research misconduct in 

research supported by U.S. Public 

Health Service (PHS) funds, specifically 

National Institute of Allergy and 

Infectious Diseases (NIAID), National 

Institutes of Health (NIH), grant R01 

AI125216. The administrative actions, 

including debarment for a period of ten 

(10) years, were implemented beginning 

on January 7, 2021, and are detailed 

below. 

FOR FURTHER INFORMATION CONTACT: 

Wanda K. Jones, Dr. P.H., Acting 

Director, Office of Research Integrity, 

1101 Wootton Parkway, Suite 240, 

Rockville, MD 20852, (240) 453–8200. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that the Office of Research 

Integrity (ORI) has taken final action in 

the following case: 

Yibin Lin, Ph.D., University of Texas 

Health Science Center: Based on the 

report of an assessment conducted by 

UTHealth, Respondent’s admission, and 

analysis conducted by ORI in its 

oversight review, ORI found that Dr. 

Yibin Lin, former postdoctoral fellow, 

McGovern Medical School, UTHealth, 

engaged in research misconduct in 

research supported by PHS funds, 

specifically NIAID, NIH, grant R01 

AI125216. 

ORI found that Respondent engaged 

in research misconduct by knowingly 

and intentionally falsifying, fabricating, 

and plagiarizing data and text reported 

in the following published papers, 

which have been retracted, and 

manuscripts: 

Published Papers 

• Efficient Method for Genomic DNA 

Mutagenesis in E. coli. bioRxiv 2020. 

doi: https://doi.org/10.1101/ 

2020.05.16.097097. 

• A simple and efficient method for 

in vitro site directed mutagenesis. 

bioRxiv 2020. doi: https://doi.org/ 

10.1101/2020.05.16.100107. 

• A restriction-free method for gene 

reconstitution. bioRxiv 2020. doi: 

https://doi.org/10.1101/ 

2020.05.20.107631. 

• Efficient Method for Protein 

Crystallization. bioRxiv 2020. doi: 

https://doi.org/10.1101/ 

2020.05.24.113860. 

• Rice Tolerance to Drought is 

Complex Both Physiologically and 

Genetically. bioRxiv 2020. doi: https://

doi.org/10.1101/2020.08.19.258293. 

• ITS2 Pretrial Gene Identification 

Related to Seed and Flower 

Identification for Cyclea barbata. 

bioRxiv 2020. doi: https://doi.org/ 

10.1101/2020.08.20.259804. 

Manuscripts Submitted to bioRxiv in 

2020 and Not Published 

• Analysis of the Deduced Amino 

Acid Sequence of Lectin-like Protein. 

• Comprehensive proteomic 

characterization of ovarian tumors. 

• Insight into the membrane protein 

localization and antibiotic resistance by 

fluorescence microscopy. 

• Invariant States of the Algebra of 

Observables. 

• The Biochemical Analysis the 

Expression Levels of Pre-synaptic, Postsynaptic, Nuclear and Mitochondrial 

Markers. 

• The Overall Difference Analysis of 

Antioxidant of Isoflavone from Three 

Kinds of Soybean Stems. 

• The Overall Difference Analysis of 

Antioxidant of Isoflavone from Three 

Kinds of Tomato. 

Manuscript Rejected by bioRxiv and 

Resubmitted to medRxiv in 2020 

• Invariant States of the Algebra of 

Observables. 

ORI finds that Respondent knowingly 

and intentionally falsified, fabricated, 

and plagiarized the whole content of six 

(6) papers and eight (8) manuscripts, 

falsely created fictitious author names 

and affiliations without listing himself 

as an author to disguise himself from 

being the offender, and submitted them 

for publication in bioRxiv and medRxiv, 

open access preprint repositories, by 

falsely assembling random paragraphs 

of text, tables, and figures from previous 

publications and manuscripts to 

improve his citation metrics. 

Dr. Lin entered into a Voluntary 

Exclusion Agreement (Agreement) and 

agreed to the following: 

(1) Because the Respondent also 

attempted to deceive the online 

publication sites bioRxiv and medRxiv 

by creating fictitious author names and 

affiliations without listing himself as an 

author, Respondent agreed to exclude 

himself voluntarily for a period of ten 

(10) years beginning on January 7, 2021, 

from any contracting or subcontracting 

with any agency of the United States 

Government and from eligibility for or 

involvement in nonprocurement 

programs of the United States 

Government referred to as ‘‘covered 

transactions’’ pursuant to HHS’ 

Implementation (2 CFR part 376) of 

OMB Guidelines to Agencies on 

Governmentwide Debarment and 

Suspension, 2 CFR part 180 (collectively 

the ‘‘Debarment Regulations’’); and 

(2) Respondent agreed to exclude 

himself voluntarily from serving in any 

advisory capacity to PHS including, but 

not limited to, service on any PHS 

advisory committee, board, and/or peer 

review committee, or as a consultant for 

a period of ten (10) years, beginning on 

January 7, 2021. 

Dated: January 29, 2021. 

Wanda K. Jones, 

Acting Director, Office of Research Integrity, 

Office of the Assistant Secretary for Health. 

[FR Doc. 2021–02273 Filed 2–3–21; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


jbell on DSKJLSW7X2PROD with NOTICES